Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myeloma
体成分可预测不良预后，并通过单细胞分析揭示抗BCMA CAR-T细胞治疗的多发性骨髓瘤患者的免疫代谢功能障碍。
期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70314
Wiemers, Thomas C; Rade, Michael; Grieb, Nora; Ferle, Maximilian; Dermendzhiev, Tihomir; Fandrei, David; Born, Patrick; Fischer, Luise; Seiffert, Sabine; Grahnert, Anja; Friedrich, Maik; Baber, Ronny; Kreuz, Markus; Metzeler, Klaus H; Herling, Marco; Herling, Carmen D; Jentzsch, Madlen; Franke, Georg-Nikolaus; Boldt, Andreas; Neumuth, Thomas; Shah, Urvi A; Köhl, Ulrike; Reiche, Kristin; Denecke, Timm; Platzbecker, Uwe; Vučinić, Vladan; Meyer, Hans-Jonas; Merz, Maximilian
T细胞
单细胞
多发性骨髓瘤
代谢
T细胞
骨髓瘤
细胞生物学
免疫代谢
免疫/内分泌
